Augmedix Debt to Equity

The latest debt-to-equity ratio for AUGX is 2.95. That is above the sector sector average of 0.2. Investors often review this figure alongside Augmedix's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AUGX currently prints 2.95 for debt-to-equity ratio, while the sector average sits near 0.2. That is roughly 1368.3% above the sector mean. Large gaps often invite a closer look at Augmedix's growth, margins, and balance sheet.

A debt-to-equity ratio of 2.95 for Augmedix is not 'good' or 'bad' on its own. Compare it with the peer average (0.2) and with AUGX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting AUGX's debt-to-equity ratio (2.95), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.